HP appoints former GSK CEO Emma Walmsley as CEO

Key Takeaways

• Emma Walmsley becomes HP Inc.’s CEO on 4 January 2027, after a 9‑year tenure at GSK.
• Current interim CEO Bruce Broussard will transition to Chair of the Board on the same date.
• Wal‑sley's track record includes a £12 billion revenue turnaround at GSK, a 17‑year stint at L’Oréal, and 7 years on Microsoft’s board.
• The leadership shuffle marks the first time a former pharma chief leads a global PC/printing firm.

Overview of the Leadership Change

HP Inc. (NASDAQ: HPQ) announced that its board of directors voted unanimously to install Emma Walmsley as chief executive officer, effective 4 January 2027. Walmsley, best known for steering GlaxoSmithKline (GSK) through a multi‑year transformation, will replace Bruce Broussard, who has been serving as interim CEO since February 2026. Upon Walmsley’s arrival, Broussard will assume the role of Chair of the Board, succeeding Chip Bergh.

“Emma brings a proven record of strategic focus, operational discipline and talent development – qualities that align with HP’s next phase of growth,” said HP Chair Chip Bergh in the company release.

Emma Walmsley – From Pharma to Tech

Walmsley's tenure at GSK delivered a step‑change in operating performance, tightening the balance sheet and positioning the firm for a £2 bn cost‑savings program after the consumer‑health split. Her experience in large‑scale transformation and talent pipelines is being tapped to accelerate HP’s shift toward high‑value services such as Hybrid Cloud printing and AI‑driven device management.

Bruce Broussard – Interim CEO to Chair

Broussard’s shift to board chair will give HP continuity while Walmsley focuses on product‑to‑market execution.

Strategic Implications for HP

1. Diversified leadership – Bringing a pharma‑grade focus on pipeline development may accelerate HP’s move from commodity hardware to subscription‑based services.
2. Financial discipline – Walmsley’s success in cost‑savings and margin expansion at GSK suggests tighter expense control for HP’s $63 bn revenue stream.
3. Talent pipeline – Her emphasis on leadership bench building aligns with HP’s announced 2028 talent‑development program targeting 1,500 emerging leaders worldwide.

Bottom Line

Emma Walmsley's appointment as HP’s next chief executive signals a bold, cross‑industry bet: leveraging a proven transformation leader from the pharmaceutical world to drive HP’s evolution from a hardware‑centric company to a services‑rich technology platform. While interim CEO Bruce Broussard moves to chair the board, the dual transition provides both continuity and fresh strategic direction. Stakeholders can expect a sharper focus on high‑margin services, disciplined cost management, and a reinforced leadership pipeline—all aimed at sustaining HP’s competitiveness in a rapidly changing market.

For further details, visit hp.com.